Evaluation of oclacitinib maleate and prednisolone combined therapy for the control of atopic dermatitis in dogs: A controlled clinical trial

Ähnliche Einträge

• Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration
  von: Wendie Roldan Villalobos, et al.
  Veröffentlicht: (2025)
• Comparative study of a commercial formula containing natural antimicrobials versus oral cephalexin or topical chlorhexidine‐miconazole therapies for treating superficial pyoderma in dogs
  von: Vanessa Cunningham Gmyterco, et al.
  Veröffentlicht: (2025)
• Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis
  von: Sophie Forster, et al.
  Veröffentlicht: (2025)
• Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial
  von: Sophie Forster, et al.
  Veröffentlicht: (2025)
• A placebo‐controlled, double‐blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs
  von: Laura Schäfer, et al.
  Veröffentlicht: (2024)